Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: Implications for angiogenesis

Trends in Cardiovascular Medicine

Volumn 9, Issue 3-4, 1999, Pages 70-77

  Haas, T L ^a   Madri, Joseph A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; GELATINASE A; GROWTH FACTOR; INTEGRIN; METALLOPROTEINASE; SCLEROPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ANIMAL CELL; CELL INTERACTION; CELL SURFACE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; MECHANORECEPTOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL COMMUNICATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0033117167     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(99)00014-6     Document Type: Review

References (71)

1. Azzam H.S., Thompson E.W. Collagen-induced activation of the Mr 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res. 52:1992;4540-4544.
2. Barakat A.I., Davies P.F. Mechanisms of shear stress transmission and transduction in endothelial cells. Chest. 114:1998;58S-63S.
3. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol. 7:1995;728-735.
4. Brooks P.C., Stromblad S., Sanders L.C.et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alphaV beta3. Cell. 85:1996;683-693.
5. Brooks P.C., Silletti S., von Schalscha T.L., Friedlander M., Cheresh D.A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell. 92:1998;391-400.
6. Cao J., Sato H., Takino T., Seiki M. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem. 270:1995;801-805.
7. Carmeliet P., Collen D. Development and disease in proteinase-deficient mice. role of the plasminogen, matrix metalloproteinase and coagulation system Thromb Res. 91:1998;255-285.
8. Chicurel M.E., Chen C.S., Ingber D.E. Cellular control lies in the balance of forces. Curr Opin Cell Biol. 10:1998;232-239.
9. Corcoran M.L., Kleiner D.E., Stetler-Stevenson W.G. Regulation of matrix metalloproteinases during extracellular matrix turnover. Adv Exp Med Biol. 385:1995;151-159.
10. Corcoran M.L., Emmert-Buck M.R., McClanahan J.L., Pelina-Parker M., Stetler-Stevenson W.G. TIMP-2 mediates cell surface binding of MMP-2. Adv Exp Med Biol. 389:1996;295-304. a.
11. Corcoran M.L., Hewitt R.E., Kleiner D.E. Jr., Stetler-Stevenson W.G. MMP-2. expression, activation and inhibition Enzyme Protein. 49:1996;7-19. b.
12. Cornelius L.A., Nehring L.C., Roby J.D., Parks W.C., Welgus H.G. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J Invest Dermatol. 105:1995;170-176.
13. Cowell S., Knauper V., Stewart M.L., D'Ortho M.P., Stanton H., Hembry R.M., Lopez-Otin C., Reynolds J.J., Murphy G. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase. associated activation of gelatinase A, gelatinase B and collagenase 3 Biochem J. 331:1998;453-458.
14. Davis G.E., Camarillo C.W. An alpha2 beta1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res. 224:1996;39-51.
15. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res. 77:1995;863-868.
16. Foda H.D., George S., Conner C., Drews M., Tompkin D.C., Zucker S. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate (PMA). a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase Lab Invest. 74:1996;538-545.
17. Galardy R.E., Grobelny D., Foellmer H.G., Fernandez L.A. Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide. Cancer Res. 54:1994;4715-4718.
18. Gilles C., Polette M., Seiki M., Birembaut P., Thompson E.W. Implication of collagen type 1-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab Invest. 76:1997;651-660.
19. Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. Tissue inhibitors of metalloproteinases. structure, regulation and biological functions Eur J Cell Biol. 74:1997;111-122.
20. Graesser D., Mahooti S., Haas T., Davis S., Clark R.B., Madri J.A. The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. Lab Invest. 78:1998;1445-1458.
21. Haas T.L., Davis S.J., Madri J.A. Three dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem. 273:1998;3604-3610.
22. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
23. Harendza S., Polluck A.S., Mertens P.R., Lovett D.H. Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J Biol Chem. 270:1995;18,786-18,796.
24. Hiraoka N., Allen E., Apel I.J., Gyetko M.R., Weiss S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 95:1998;365-377.
25. Ho W., Heinemann C., Hangan D., Uniyal S., Morris V.L., Chan B.M.C. Modulation of in vivo migratory function of alpha2 beta1 integrin in mouse liver. Mol Biol Cell. 8:1997;1863-1875.
26. Hudlicka O., Brown M.D., Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev. 72:1992;369-417.
27. Huhtala P., Chow L.T., Tryggvason K. Structure of the human type IV collagenase gene. J Biol Chem. 265:1990;11,077-11,082.
28. Huhtala P., Humphries M.J., McCarthy J.B., Tremble P.M., Werb Z., Damsky C.H. Cooperative signalling by alpha5 beta1 and alpha4 beta1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol. 129:1995;867-879.
29. Hynes R.O. Integrins. versatility, modulation and signaling in cell adhesion Cell. 69:1992;11-25.
30. Imai K., Ohta S., Matsumoto T.et al. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol. 151:1997;245-256.
31. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1998;1048-1051.
32. Jackson C.J., Knop A., Giles I., Jenkins K., Schrieber L. VLA-2 mediates the interaction of collagen with endothelium during in vitro vascular tube formation. Cell Biol Int. 18:1994;859-867.
33. Keely P.J., Fong A.M., Zutter M.M., Santoro S.A. Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense alpha 2 integrin mRNA in mammary cells. J Cell Sci. 108:1995;595-607.
34. Khachigian L.M., Lindner V., Williams A.J., Collins T. Egr-1-induced endothelial gene expression. a common theme in vascular injury Science. 271:1996;1427-1431.
35. Langholz O., Rockel D., Mauch C.et al. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha1 beta1 and alpha2 beta1 integrins. J Cell Biol. 131:1995;1903-1915.
36. Lewalle J.M., Munaut C., Pichot B., Cataldo E., Baramova E., Foidart J.M. Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J Cell Physiol. 165:1995;475-483.
37. Lohi L., Lehti K., Westermarck J., Kahari V.M., Keski-Oja J. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem. 239:1996;239-247.
38. Madri J.A., Sankar S., Romanic A.M. Angiogenesis. Clark R.A.F. The Molecular and Cellular Biology of Wound Repair. 2nd Ed:1996;355-371 Plenum Press, New York.
39. Madri J.A., Pratt B.M. Endothelial cell-matrix interactions. in vitro models of angiogenesis J Histochem Cytochem. 34:1986;85-91.
40. Madri J.M., Williams S.K. Capillary endothelial cell cultures. phenotypic modulation by matrix components J Cell Biol. 97:1983;153-165.
41. Matrisian L. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:1990;121-125.
42. Mertens P.R., Harendza S., Pollock A.S., Lovett D.H. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase-2 transcription is mediated by YB-1. J Biol Chem. 272:1997;22,905-22,912.
43. Mignatti P., Rifkin D.B. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein. 49:1996;117-137.
44. Monsky W.L., Kelly T., Lin C.Y.et al. Binding and localization of Mr 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res. 53:1993;3159-3164.
45. Montesano R., Orci L. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell. 42:1985;469-477.
46. Murphy G., Knauper V. Relating matrix metalloproteinase structure to function. why the "hemopexin" domain? Matrix Biol. 15:1997;511-518.
47. Pei D., Weiss S.J. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem. 271:1996;9135-9140.
48. Pepper M.S. Transforming growth factor-beta. vasculogenesis, angiogenesis and vessel wall integrity Cytokine Growth Factor Rev. 8:1997;21-43. a.
49. Pepper M.S. Manipulating angiogenesis. from basic science to the bedside Arterioscler Thromb Vasc Biol. 17:1997;605-619. b.
50. Riikonen T., Westermarck J., Koivisto L., Broberg A., Kahari V.M., Heino J. Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1 (I) gene expression. J Biol Chem. 270:1995;13,548-13,552.
51. Romanic A.M., Madri J.A. The induction of 72-kD Gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol. 125:1994;1165-1178.
52. Roskelly C.D., Srebrow A., Bissell M.J. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opin Cell Biol. 7:1995;736-747.
53. Sato H., Takino T., Okada Y.et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:1994;61-65.
54. Sato H., Okada Y., Seiki M. Membrane type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb Haemost. 78:1997;497-500.
55. Schnaper H.W., Grant D.S., Stetler-Stevenson W.G.et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol. 156:1993;235-246.
56. Silverman E.S., Collins T. Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol. 154:1999;665-670.
57. Stromblad S., Cheresh D.A. Integrins, angiogenesis and vascular cell survival. Chem Biol. 3:1996;881-885.
58. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. J Biol Chem. 270:1995;5331-5338.
59. Sudbeck B.D., Pilcher B.K., Welgus H.G., Parks W.C. Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J Biol Chem. 272:1997;22,103-22,110.
60. Takahashi M., Ishida T., Traub O., Corson M.A., Berk B.C. Mechanotransduction in endothelial cells. temporal signaling events in response to shear stress J Vasc Res. 34:1997;212-219.
61. Tomasek J.J., Halliday N.L., Updike D.L.et al. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem. 272:1997;7482-7487.
62. Tremble P., Damsky C.H., Werb Z. Components of the nuclear signaling cascade that regulate collagenase gene expression in response to integrin-derived signals. J Cell Biol. 129:1995;1707-1720.
63. Tremble P.M., Lane T.F., Sage E.H., Werb Z. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol. 121:1993;1433-1444.
64. Vernon R.B., Sage E.H. Between molecules and morphology. extracellular matrix and creation of vascular form Am J Pathol. 147:1995;873-883.
65. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., Shapiro S.D., Senior R.M., Werb Z. MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:1998;411-422.
66. Woessner J.F. The family of matrix metalloproteinases. Ann NY Acad Sci. 732:1994;11-21.
67. Wojtowicz-Praga S.M., Dickson R.B., Hawkins M.J. Matrix metalloproteinase inhibitors. Invest New Drugs. 15:1997;61-75.
68. Xu J., Zutter M.M., Santoro S.A., Clark R.A.F. A three-dimensional collagen lattice activates NF-κB in human fibroblasts. role in integrin alpha2 gene expression and tissue remodeling J Cell Biol. 140:1998;709-719.
69. Xu J., Clark R.A.F. A three-dimensional collagen lattice induces protein kinase C-ζ activity. role in alpha2 integrin and collagenase mRNA expression J Cell Biol. 136:1997;473-483.
70. Zhu X., Assoian R.K. Integrin-dependent activation of MAP kinase. a link to shape-dependent cell proliferation Mol Biol Cell. 6:1995;273-282.
71. Zucker S., Drews M., Conner C.et al. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase1 (MT1-MMP). J Biol Chem. 273:1998;1216-1222.